๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersi...
Status
Completed
Location
Bausch Health Site 18
Start Date
2018-09-13
Trial ID
NCT03515044
Study RNLC3132 is a Phase 3, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
Bausch Site 591
Start Date
2022-08-03
Trial ID
NCT05297448
Treatments Being Tested
Hepatitis C is the leading cause of chronic liver disease and cirrhosis in ...
Status
Terminated
Location
Philadelphia VA Medical Center
Start Date
2016-11-17
Trial ID
NCT01951209
Metabolic syndrome is a condition involving elevated levels of fat in the b...
Status
Completed
Location
University of Kentucky Center for Clinical and Translational Science
Start Date
2015-03
Trial ID
NCT02124512
Treatments Being Tested
The primary objective of this study is to assess the efficacy of rifaximin ...
Status
Completed
Location
Salix Investigative Site
Start Date
2013-06
Trial ID
NCT01904409
Study RNLC3131 is a Phase 3, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
Bausch Site 182
Start Date
2022-04-07
Trial ID
NCT05071716
Treatments Being Tested
Using a new formulation of rifaximin, a non-absorbable antibiotic, to test ...
Status
Recruiting
Location
Richmond VA Medical Center
Start Date
2024-12-30
Trial ID
NCT06718686
Treatments Being Tested